Activation of the human terminal complement pathway in atherosclerosis
- 1 November 1987
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 45 (2) , 147-155
- https://doi.org/10.1016/0090-1229(87)90029-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaqueAtherosclerosis, 1985
- Immunoglobulins and complement components in human aortic atherosclerotic intimaAtherosclerosis, 1985
- Immunological and microbiological factors in the pathogenesis of atherosclerosisClinical Immunology and Immunopathology, 1985
- Atherosclerosis: New horizonsHuman Pathology, 1985
- Membrane damage by complementBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
- Serum spreading factor (vitronectin) is present at the cell surface and in tissues.Proceedings of the National Academy of Sciences, 1983
- Fluid-phase SC5b-8 complex of human complement: generation and isolation from serum.The Journal of Immunology, 1981
- Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasmaJournal of Immunological Methods, 1981
- CHOLESTEROL AND ATHEROMA LIPIDS ACTIVATE COMPLEMENT AND STIMULATE GRANULOCYTES - A POSSIBLE MECHANISM FOR AMPLIFICATION OF ISCHEMIC-INJURY IN ATHEROSCLEROTIC STATES1981
- Isolation of human S-protein, an inhibitor of the membrane attack complex of complement.Journal of Biological Chemistry, 1979